✦ LIBER ✦

Pretreatment with P2Y12 inhibitors in non–ST-segment elevation acute coronary syndrome: Time to revise the guidelines?

✍ Scribed by Cayla, Guillaume; Collet, Jean-Philippe; Silvain, Johanne; Montalescot, Gilles

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet glycoprotein inhibitors may red

✍ David L. Brown 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Practical approach to incorporating new

✍ William E Boden 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 487 KB

Influence of updated guidelines on short

✍ B. Vogel; S. Hahne; I. Kozanli; K. Kalla; R. Jarai; M. Freynhofer; P. Smetana; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Low-molecular-weight heparin in patients

✍ Shaun G Goodman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 735 KB

Eptifibatide does not suppress the incre

✍ Alexey A. Mazaev; Yaroslav A. Naimushin; Valery P. Masenko; Mikhail Y. Ruda; Ale 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 205 KB

Angiographic Outcomes With Early Eptifib

✍ Kunadian, Vijay; Giugliano, Robert P.; Newby, L. Kristin; Zorkun, Cafer; Guo, Ji 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 606 KB